These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 30372726)

  • 61. [Patient with Recurrent Breast Cancer Who Developed Radiation Esophagitis with Severe Esophageal Stenosis after Combined Bevacizumab and Paclitaxel Therapy-A Case Report].
    Matsuura K; Osaki A; Ichinose Y; Fujimoto A; Nukui A; Saeki T
    Gan To Kagaku Ryoho; 2020 Nov; 47(11):1605-1608. PubMed ID: 33268737
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [A complete response following treatment with Paclitaxel and bevacizumab for metastatic breast cancer].
    Tsubota Y; Sueoka N; Yamamoto D
    Gan To Kagaku Ryoho; 2014 Nov; 41(12):1954-6. PubMed ID: 25731387
    [TBL] [Abstract][Full Text] [Related]  

  • 63. A remarkable case of cutaneous metastatic breast carcinoma.
    Santiago F; Saleiro S; Brites MM; Frutuoso C; Figueiredo A
    Dermatol Online J; 2009 Jul; 15(7):10. PubMed ID: 19903438
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Efficacy and safety of nab-paclitaxel combined with carboplatin in Chinese patients with melanoma.
    Guo YQ; Ding Y; Li DD; Li JJ; Peng RQ; Wen XZ; Zhang X; Zhang XS
    Med Oncol; 2015 Sep; 32(9):234. PubMed ID: 26298530
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Safety and efficacy of bevacizumab combined with taxanes in the first-line treatment of metastatic breast cancer: ATHENA study-France].
    Hardy-Bessard AC; Delva R; Pivot X; Espié M; Dalenc F; Coulon Sfairi MA; Monnier A; Serin D; Veyret C; Lortholary A; Pavlyuk M; Kockler L; Pierga JY
    Bull Cancer; 2012 Jun; 99(6):609-18. PubMed ID: 22665515
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Infusional fluorouracil, epirubicin, and cisplatin followed by weekly paclitaxel plus bevacizumab in locally advanced breast cancer with unfavorable prognostic features.
    Balduzzi A; Montagna E; Bagnardi V; Torrisi R; Bertolini F; Mancuso P; Scarano E; Viale G; Veronesi P; Cardillo A; Orlando L; Goldhirsch A; Colleoni M
    Anticancer Drugs; 2009 Mar; 20(3):197-203. PubMed ID: 19182679
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Phase II open-label study of bevacizumab combined with neoadjuvant anthracycline and taxane therapy for locally advanced breast cancer.
    Clavarezza M; Turazza M; Aitini E; Saracchini S; Garrone O; Durando A; De Placido S; Bisagni G; Levaggi A; Bighin C; Restuccia E; Scalamogna R; Galli A; Del Mastro L
    Breast; 2013 Aug; 22(4):470-5. PubMed ID: 23642526
    [TBL] [Abstract][Full Text] [Related]  

  • 68. SAKK 24/09: safety and tolerability of bevacizumab plus paclitaxel vs. bevacizumab plus metronomic cyclophosphamide and capecitabine as first-line therapy in patients with HER2-negative advanced stage breast cancer - a multicenter, randomized phase III trial.
    Rochlitz C; Bigler M; von Moos R; Bernhard J; Matter-Walstra K; Wicki A; Zaman K; Anchisi S; Küng M; Na KJ; Bärtschi D; Borner M; Rordorf T; Rauch D; Müller A; Ruhstaller T; Vetter M; Trojan A; Hasler-Strub U; Cathomas R; Winterhalder R;
    BMC Cancer; 2016 Oct; 16(1):780. PubMed ID: 27724870
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Recurrence of skin and lymph nodes from asynchronous breast cancer successfully treated with paclitaxel and toremifene therapy--a case report].
    Sakurai K; Enomoto K; Tani M; Kitajima A; Amano S; Shiono M
    Gan To Kagaku Ryoho; 2008 Nov; 35(12):2222-4. PubMed ID: 19106577
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Bevacizumab and paclitaxel for breast cancer patients with central nervous system metastases: a case series.
    Labidi SI; Bachelot T; Ray-Coquard I; Mosbah K; Treilleux I; Fayette J; Favier B; Galy G; Blay JY; Guastalla JP
    Clin Breast Cancer; 2009 May; 9(2):118-21. PubMed ID: 19433393
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Adjuvant bevacizumab-containing therapy in triple-negative breast cancer (BEATRICE): primary results of a randomised, phase 3 trial.
    Cameron D; Brown J; Dent R; Jackisch C; Mackey J; Pivot X; Steger GG; Suter TM; Toi M; Parmar M; Laeufle R; Im YH; Romieu G; Harvey V; Lipatov O; Pienkowski T; Cottu P; Chan A; Im SA; Hall PS; Bubuteishvili-Pacaud L; Henschel V; Deurloo RJ; Pallaud C; Bell R
    Lancet Oncol; 2013 Sep; 14(10):933-42. PubMed ID: 23932548
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Bevacizumab specifically decreases elevated levels of circulating KIT+CD11b+ cells and IL-10 in metastatic breast cancer patients.
    Cattin S; Fellay B; Pradervand S; Trojan A; Ruhstaller T; Rüegg C; Fürstenberger G
    Oncotarget; 2016 Mar; 7(10):11137-50. PubMed ID: 26840567
    [TBL] [Abstract][Full Text] [Related]  

  • 73. When a good call leads to a bad connection: colovesical fistula in colorectal cancer treated with bevacizumab.
    Chen J; Smalligan RD; Nadesan S
    Hosp Pract (1995); 2016 Aug; 44(3):120-2. PubMed ID: 27309405
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Erythematous nodules of the hand: a rare site of metastatic breast carcinoma.
    Vijaya B; ; Veeranna S; Manjunath GV
    Indian J Dermatol Venereol Leprol; 2011; 77(6):695-8. PubMed ID: 22016277
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Multifocal scalp hair loss.
    Shamsadin S; Esfandiarpoor I; Zeinali H; Kalantari B; Ebrahimi H
    Dermatol Online J; 2006 May; 12(4):24. PubMed ID: 17083879
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [New treatment approaches in breast cancer].
    Spirig C; Thürlimann B; Huober J
    Ther Umsch; 2008 Apr; 65(4):207-10. PubMed ID: 18622912
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Cardiac sequelae of doxorubicin and paclitaxel as induction chemotherapy prior to high-dose chemotherapy and peripheral blood progenitor cell transplantation in women with high-risk primary or metastatic breast cancer.
    Klein JL; Rey PM; Dansey RD; Karanes C; Du W; Abella E; Cassells L; Hamm C; Peters WP; Baynes RD
    Bone Marrow Transplant; 2000 May; 25(10):1047-52. PubMed ID: 10828864
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [A Case of Recurrent Breast Cancer with Carcinomatous Pleurisy Successfully Treated with Paclitaxel and Bevacizumab after Radical Mastectomy].
    Sakaguchi N; Moriya T; Yamazaki T; Yamagishi Y; Hasegawa S; Tsuda H; Hase K; Yamamoto J
    Gan To Kagaku Ryoho; 2015 Jun; 42(6):751-3. PubMed ID: 26199251
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer.
    Sandler A; Gray R; Perry MC; Brahmer J; Schiller JH; Dowlati A; Lilenbaum R; Johnson DH
    N Engl J Med; 2006 Dec; 355(24):2542-50. PubMed ID: 17167137
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Dose-intense paclitaxel, etoposide and cyclophosphamide: a safe and active regimen for tumor cytoreduction and stem cell mobilization in metastatic breast cancer.
    Bilgrami S; Feingold JM; Bona RD; Edwards RL; Khan AM; Rodriguez-Pinero F; Khan IA; Kazierad D; Clive J; Tutschka PJ
    Bone Marrow Transplant; 2000 Jan; 25(2):123-30. PubMed ID: 10673668
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.